TPST Tempest Therapeutics, Inc.
Nasdaq · SEC CIK 1544227 · EDGAR
- Bought, last 12 months
- $1.00M 2 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 70 since 2021-07-06, latest 2026-06-23 16:56
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Angel Matthew | CEO, Pres, Dir, 10% | $1.00M | — |
Transactions 9
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-06-23 16:56 | 2026-03-24 | TPST | Angel Matthew | CEO, Pres, Dir, 10% | P - Purchase | $2.16 | +231.5K | 231.5K | New | +$500.0K |
| I | 2026-03-25 | 2026-03-24 | TPST | Angel Matthew | CEO, Pres, Dir, 10% | P - Purchase | $2.16 | +231.5K | 231.5K | New | +$500.0K |
| M | 2024-08-12 | 2024-08-08+ | TPST | Versant Venture Capital VI, L.P. | 10% | S - Sale | $1.23 | -788.0K | 597.9K | -57% | -$966.8K |
| 2024-07-08 | 2024-07-03 | TPST | Brady Stephen R | Pres, CEO, Dir | P - Purchase | $2.11 | +35.0K | 46.4K | +308% | +$73.8K | |
| 2024-07-03 | 2024-07-02 | TPST | Whiting Samuel | Chief Medical Off | P - Purchase | $2.13 | +4,672 | 9,573 | +95% | +$9,951 | |
| 2024-07-02 | 2024-06-28 | TPST | Trojanowski Justin | Corp. Ctrl | P - Purchase | $2.16 | +7,500 | 22.2K | +51% | +$16.2K | |
| I | 2022-05-03 | 2022-04-29 | TPST | Woiwode Thomas | Dir, 10% | P - Purchase | $2.36 | +2.12M | 2.12M | New | +$5.00M |
| 2022-01-11 | 2022-01-07 | TPST | Dubensky Thomas W. | Pres, Dir | P - Purchase | $4.78 | +2,000 | 113.3K | +2% | +$9,560 | |
| 2022-01-10 | 2022-01-06 | TPST | Whiting Samuel | Chief Medical Off | P - Purchase | $4.80 | +1,700 | 1,901 | +846% | +$8,160 |
Purchase Sale Sale after option exercise All abbreviations